PREDAIR Drug Patent Profile
✉ Email this page to a colleague
When do Predair patents expire, and when can generic versions of Predair launch?
Predair is a drug marketed by Pharmafair and is included in two NDAs.
The generic ingredient in PREDAIR is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Predair
A generic version of PREDAIR was approved as prednisolone sodium phosphate by BAUSCH AND LOMB on July 29th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREDAIR?
- What are the global sales for PREDAIR?
- What is Average Wholesale Price for PREDAIR?
Summary for PREDAIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 5,152 |
| DailyMed Link: | PREDAIR at DailyMed |
US Patents and Regulatory Information for PREDAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | PREDAIR | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 088415-001 | Feb 29, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Pharmafair | PREDAIR FORTE | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 088165-001 | Mar 28, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
